BioCentury | Jul 13, 2015
Financial News

S1 Biopharma withdraws IPO

...York, N.Y. Business: Genitourinary Date announced: 2015-06-25 Type: IPO Underwriters: MLV; Northland Securities Inc. Note: S1 Biopharma...
BioCentury | Apr 6, 2015
Finance

Fundamental rally

...plc (LSE) 12/4/14 Up to £20M ($29.7M) Ph I AutoGenomics Inc. 10/7/14 $45M Mkt (diagnostic) S1 Biopharma Inc....
BioCentury | Jan 5, 2015
Finance

2015 Financial Markets Preview: Show me in 2015

...Ph II PolyPid Ltd. 10/14/14 $20M Pilot AutoGenomics Inc. 10/7/14 Up to $60M Mkt (diagnostic) S1 Biopharma Inc....
BioCentury | Dec 8, 2014
Financial News

S1 Biopharma amends IPO

...$24.5 million Shares: 1.8 million Price: $12-$14 Underwriters: MLV; Northland Securities Inc. Overallotment: 262,500 Note: S1 Biopharma...
BioCentury | Nov 27, 2014
Financial News

S1 Biopharma amends IPO

S1 Biopharma Inc. (New York, N.Y.) amended its IPO on NASDAQ and plans to sell 1.75 million units at $12-$14. At $13, the company would raise $22.8 million and be valued at $105.7 million. Each...
BioCentury | Nov 17, 2014
Financial News

S1 Biopharma amends IPO

S1 Biopharma Inc. , New York, N.Y. Business: Genitourinary Date announced: 2014-11-10 Type: IPO To be raised: Up to $44.3 million Shares: 2.8 million Price: $12-$14 Underwriters: MLV; Northland Securities Inc. Overallotment: 412,500 Note: The company...
BioCentury | Oct 27, 2014
Financial News

S1 Biopharma amends IPO

S1 Biopharma Inc. , New York, N.Y. Business: Genitourinary Date announced: 2014-10-22 Type: IPO To be raised: Up to $38.5 million Shares: 2.8 million Price: $12-$14 Underwriter: MLV Overallotment: 412,500 Note: The company amended its IPO...
BioCentury | Oct 24, 2014
Financial News

S1 Biopharma sets IPO range

...$12-$14. At $13, the company would raise $35.8 million and be valued at $118.6 million. S1 Biopharma...
BioCentury | Oct 6, 2014
Finance

4Q14 Financial Markets Preview: 'Perfect world' - for now

...IPO; (H) Being spun out of Ampio Pharmaceuticals Inc. (NYSE-M:AMPE); Source: BCIQ: BioCentury Online Intelligence S1 Biopharma Inc....
BioCentury | Oct 6, 2014
Financial News

S1 Biopharma proposes IPO

S1 Biopharma Inc. , New York, N.Y. Business: Genitourinary Date announced: 2014-10-01 Type: IPO To be raised: Up to $40.3 million Shares: TBD Price: TBD Underwriter: MLV Note: The company is seeking to list its shares...
Items per page:
1 - 10 of 14
BioCentury | Jul 13, 2015
Financial News

S1 Biopharma withdraws IPO

...York, N.Y. Business: Genitourinary Date announced: 2015-06-25 Type: IPO Underwriters: MLV; Northland Securities Inc. Note: S1 Biopharma...
BioCentury | Apr 6, 2015
Finance

Fundamental rally

...plc (LSE) 12/4/14 Up to £20M ($29.7M) Ph I AutoGenomics Inc. 10/7/14 $45M Mkt (diagnostic) S1 Biopharma Inc....
BioCentury | Jan 5, 2015
Finance

2015 Financial Markets Preview: Show me in 2015

...Ph II PolyPid Ltd. 10/14/14 $20M Pilot AutoGenomics Inc. 10/7/14 Up to $60M Mkt (diagnostic) S1 Biopharma Inc....
BioCentury | Dec 8, 2014
Financial News

S1 Biopharma amends IPO

...$24.5 million Shares: 1.8 million Price: $12-$14 Underwriters: MLV; Northland Securities Inc. Overallotment: 262,500 Note: S1 Biopharma...
BioCentury | Nov 27, 2014
Financial News

S1 Biopharma amends IPO

S1 Biopharma Inc. (New York, N.Y.) amended its IPO on NASDAQ and plans to sell 1.75 million units at $12-$14. At $13, the company would raise $22.8 million and be valued at $105.7 million. Each...
BioCentury | Nov 17, 2014
Financial News

S1 Biopharma amends IPO

S1 Biopharma Inc. , New York, N.Y. Business: Genitourinary Date announced: 2014-11-10 Type: IPO To be raised: Up to $44.3 million Shares: 2.8 million Price: $12-$14 Underwriters: MLV; Northland Securities Inc. Overallotment: 412,500 Note: The company...
BioCentury | Oct 27, 2014
Financial News

S1 Biopharma amends IPO

S1 Biopharma Inc. , New York, N.Y. Business: Genitourinary Date announced: 2014-10-22 Type: IPO To be raised: Up to $38.5 million Shares: 2.8 million Price: $12-$14 Underwriter: MLV Overallotment: 412,500 Note: The company amended its IPO...
BioCentury | Oct 24, 2014
Financial News

S1 Biopharma sets IPO range

...$12-$14. At $13, the company would raise $35.8 million and be valued at $118.6 million. S1 Biopharma...
BioCentury | Oct 6, 2014
Finance

4Q14 Financial Markets Preview: 'Perfect world' - for now

...IPO; (H) Being spun out of Ampio Pharmaceuticals Inc. (NYSE-M:AMPE); Source: BCIQ: BioCentury Online Intelligence S1 Biopharma Inc....
BioCentury | Oct 6, 2014
Financial News

S1 Biopharma proposes IPO

S1 Biopharma Inc. , New York, N.Y. Business: Genitourinary Date announced: 2014-10-01 Type: IPO To be raised: Up to $40.3 million Shares: TBD Price: TBD Underwriter: MLV Note: The company is seeking to list its shares...
Items per page:
1 - 10 of 14